Skip to content

Author

Adriano Aguzzi

We have 4 of 41 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

MicroRNA 517a-3p suppresses α-synuclein fibril accumulation in human glioblastoma cells

Synucleinopathies are a group of neurodegenerative disorders characterized by the misfolding, aggregation, and accumulation of α-synuclein (α-syn) into oligomeric assemblies and amyloid inclusions. Alongside neurons, glial cells can internalize pathological α-syn and play a major role in its degradation. Despite...

Lea Šustić, Elena de Cecco, Sandesh Neupane et al. · 0 citations
Open access Jul 2026

Computationally engineered cyclic peptides reduce prion levels in vitro

These results establish a mechanistic link between peptide-induced stabilization of PrPc and inhibition of prion propagation and provide a generalizable framework for designing conformational stabilizers of aggregation-prone proteins.

Elpiniki Paspali, C. Morales, Daria De Raffele et al. · 0 citations
#gene editing Open access Aug 2026

A CRISPR-Cas9 platform for primary human hepatocytes enables arrayed screening and in vivo validation of HBV host factors

Lipofection- and lentivirus-mediated protocols for CRISPR-Cas9 delivery in mouse-passaged primary human hepatocytes (mpPHH) are reported, a system that enables PHH expansion in liver-humanized mice and enables scalable genetic manipulation of mpPHH, opening new avenues for HBV research and liver disease modeling.

Ansgar F. Stenzel, Antonis Athanasiadis, Georgios Dangas et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.